Kozak & Associates, Inc.
Source: SEC Form 13F · as of Mar 2026Kozak & Associates, Inc. holds 31 biotech & pharma companies tracked by BioSniper, totaling $2.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
31
Total value held
$2.7M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 4,755 | $982K |
| GILDGILEAD SCIENCES, INC. | 3,000 | $417K |
| JNJJOHNSON & JOHNSON | 1,223 | $291K |
| MDGLMADRIGAL PHARMACEUTICALS, INC. | 424 | $223K |
| AMGNAMGEN INC | 383 | $134K |
| MRKMerck & Co., Inc. | 998 | $120K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 347 | $109K |
| ABTABBOTT LABORATORIES | 1,052 | $106K |
| ELVElevance Health Inc. | 213 | $67K |
| AZNASTRAZENECA PLC | 253 | $51K |
| ZTSZoetis Inc. | 391 | $47K |
| LLYELI LILLY & Co | 50 | $47K |
| PFEPFIZER INC | 910 | $25K |
| NVONovo Nordisk A/S | 593 | $23K |
| BMYBRISTOL MYERS SQUIBB CO | 287 | $17K |
| CORCencora Inc. | 46 | $15K |
| UTHRUNITED THERAPEUTICS Corp | 21 | $12K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 155 | $9K |
| GMOptec International, Inc. | 114 | $9K |
| MCKMcKesson Corporation | 8 | $7K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 13 | $6K |
| GEHCGE HealthCare Technologies Inc. | 59 | $4K |
| SNYSanofi | 92 | $4K |
| REGNREGENERON PHARMACEUTICALS, INC. | 5 | $4K |
| NVSNovartis AG | 21 | $3K |
| CRSPCRISPR Therapeutics AG | 26 | $1K |
| VTRSViatris Inc | 35 | $485 |
| OGNOrganon & Co. | 36 | $303 |
| LFVNLifevantage Corp | 25 | $104 |
| VVOSVivos Therapeutics Inc. | 49 | $60 |
| AVNSAvanos Medical Inc. | 4 | $58 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.